訂貨咨詢：；；；

：  865512910

備注：本公司銷售的所有產(chǎn)品僅用于生化科研試驗

HY-13011 CH5424802（別名CH5424802）機制：ALK

價格和可用性 技術(shù)參數(shù)：

M.Wt：482.62

分子式：C30H34N4O2

純度：> 98％

貯存：貯存在-20℃2年

CAS號：1256580-46-7

溶解性：DMSO≥13mg/mL水分<1.2mg/mL乙醇1.2mg/mL

生物活性：

是一種強效，選擇性，可口服ALK抑制劑。它具有*的化學(xué)腳手架，優(yōu)惠的抗腫瘤活性，對癌癥的ALK基因的改變，如非小細(xì)胞肺癌（NSCLC）細(xì)胞表達EML4-ALK融合和間變性大細(xì)胞淋巴瘤（ALCL）細(xì)胞表達NPM-ALK融合在體內(nèi)和體外。 ALK L1196M，對應(yīng)網(wǎng)守突變賦予共同抵抗激酶抑制劑，抑制和阻斷EML4-ALK L1196M驅(qū)動的細(xì)胞生長。

HY-13011   (Synonyms  CH 5424802)  Mechanisms:ALK 
Technical Data: Price and Availability of   
M.Wt: 482.62
Formula: C30H34N4O2
Purity: >98%
Storage: at -20℃ 2 years
CAS No.: 1256580-46-7
Solubility: DMSO ≥13mg/mL Water <1.2mg/mL Ethanol <1.2mg/mL     
5mg
10mg
25mg
50mg
200mg
 Biological Activity of : 
is a potent, selective, and orally available ALK inhibitor. which with a unique chemical scaffold, showing preferential antitumor activity against cancers with gene alterations of ALK, such as nonsmall cell lung cancer (NSCLC) cells expressing EML4-ALK fusion and anaplastic large-cell lymphoma (ALCL) cells expressing NPM-ALK fusion in vitro and in vivo. inhibited ALK L1196M, which corresponds to the gatekeeper mutation conferring common resistance to kinase inhibitors, and blocked EML4-ALK L1196M-driven cell growth.